Medical Communications

Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …

Bristol-Myers Squibb has bolstered its Board of Directors with the appointment of three Directors, a move which temporarily expands its …

Pranav Ullal, formerly of Chief Scientific officer of Karmagenes, has been removed from his position after a paper he published …

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …

A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …

GBI Research examines whether the US continue to dominate the global generic drug market.

Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …

Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …